Cardiol Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2024 | 2 | -$0.09 | -$0.08 | -$0.09 |
| Q3 2024 | 0 | -$0.08 | -$0.08 | -$0.08 |
| Q1 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q3 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q4 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q1 2026 | 0 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2026 | 0 | -$0.08 | -$0.08 | -$0.08 |
| Q3 2026 | 0 | -$0.08 | -$0.08 | -$0.08 |
| Q4 2026 | 0 | -$0.09 | -$0.09 | -$0.09 |
Cardiol Therapeutics Inc. Earnings Date And Information
Cardiol Therapeutics Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.07 earnings per share for the quarter, topping analysts' consensus estimates of $-0.1 by $0.03. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Cardiol Therapeutics Inc. has generated $0 earnings per share over the last year ($-0.44 diluted earnings per share) and currently has a price-to-earnings ratio of -6.28. Cardiol Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Cardiol Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/28/2024 | Q2 2024 | -$0.10 | $0 | $0 | ||
| 03/29/2024 | Q1 2024 | -$0.14 | $0 | |||
| 04/01/2024 | Q4 2023 | -$0.12 | -$0.12 | 0 | $0 | |
| 11/14/2023 | Q3 2023 | -$0.12 | -$0.09 | 0.03 | $0 | |
| 08/10/2023 | Q2 2023 | -$0.12 | -$0.12 | 0 | $0 | |
| 08/10/2023 | Q1 2023 | -$0.12 | -$0.11 | 0.01 | $0 | |
| 03/28/2023 | Q4 2022 | -$0.12 | $0 | |||
| 09/30/2022 | Q3 2022 | -$0.13 | $0 | |||
| 05/16/2022 | Q2 2022 | -$0.09 | -$0.10 | -0.01 | $0 | |
| 05/16/2022 | Q1 2022 | -$0.09 | -$0.14 | -0.05 | $0 | |
| 12/31/2021 | Q4 2021 | -$0.11 | $0 | |||
| 09/30/2021 | Q3 2021 | -$0.23 | $0 | |||
| 06/30/2021 | Q2 2021 | -$0.16 | $78,760 | |||
| 03/31/2021 | Q1 2021 | -$0.12 | -$0.26 | -0.14 | $0 | |
| 12/31/2020 | Q4 2020 | -$0.29 | $0 | |||
| 09/30/2020 | Q3 2020 | -$0.13 | $0 | |||
| 06/30/2020 | Q2 2020 | -$0.13 | $0 | |||
| 03/31/2020 | Q1 2020 | -$0.11 | $0 | |||
| 12/31/2019 | Q4 2019 | -$0.12 | $0 | |||
| 09/30/2019 | Q3 2019 | -$0.13 | $0 |
Cardiol Therapeutics Inc. Earnings: Frequently Asked Questions
-
When is Cardiol Therapeutics Inc.'s earnings date?
Cardiol Therapeutics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
Did Cardiol Therapeutics Inc. beat their earnings estimates last quarter?
In the previous quarter, Cardiol Therapeutics Inc. (:CRDL) reported $-0.07 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.1 by $0.03.
-
How can I listen to Cardiol Therapeutics Inc.'s earnings conference call?
The conference call for Cardiol Therapeutics Inc.'s latest earnings report can be listened to online.
-
How can I read Cardiol Therapeutics Inc.'s conference call transcript?
The conference call transcript for Cardiol Therapeutics Inc.'s latest earnings report can be read online.
-
How much profit does Cardiol Therapeutics Inc. generate each year?
Cardiol Therapeutics Inc. (:CRDL) has a recorded net income of $0. Cardiol Therapeutics Inc. has generated $-0.44 earnings per share over the last four quarters.
-
What is Cardiol Therapeutics Inc.'s price-to-earnings ratio?
Cardiol Therapeutics Inc. (:CRDL) has a price-to-earnings ratio of -6.28 and price/earnings-to-growth ratio is -0.62.
